Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
3R01AG011290-04S1
Application #
2622489
Study Section
Human Development and Aging Subcommittee 3 (HUD)
Project Start
1994-09-01
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Institute for Basic Research in Dev Disabil
Department
Type
DUNS #
167205090
City
Staten Island
State
NY
Country
United States
Zip Code
10314
Mehta, Pankaj D; Patrick, Bruce A; Barshatzky, Marc et al. (2015) Generation of Rabbit Monoclonal Antibody to Amyloid-?38 (A?38): Increased Plasma A?38 Levels in Down Syndrome. J Alzheimers Dis 46:1021-32
Mehta, Pankaj D; Capone, George; Jewell, Amy et al. (2007) Increased amyloid beta protein levels in children and adolescents with Down syndrome. J Neurol Sci 254:22-7
Mehta, Pankaj D; Patrick, Bruce A; Dalton, Arthur J et al. (2005) Increased serum neopterin levels in adults with Down syndrome. J Neuroimmunol 164:129-33
Percy, Maire E; Potyomkina, Zoya; Dalton, Arthur J et al. (2003) Relation between apolipoprotein E genotype, hepatitis B virus status, and thyroid status in a sample of older persons with Down syndrome. Am J Med Genet A 120A:191-8
Park, E; Alberti, J; Mehta, P et al. (2000) Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunol 95:62-9
Moalem, S; Percy, M E; Andrews, D F et al. (2000) Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93:58-66
Tsiouris, J A; Mehta, P D; Patti, P J et al. (2000) Alpha2 macroglobulin elevation without an acute phase response in depressed adults with Down's syndrome: implications. J Intellect Disabil Res 44 ( Pt 6):644-53
Mehta, P D; Patrick, B A; Dalton, A J et al. (1999) Increased levels of tau-like protein in patients with Down syndrome. Neurosci Lett 275:159-62
Mehta, P D; Dalton, A J; Mehta, S P et al. (1998) Increased plasma amyloid beta protein 1-42 levels in Down syndrome. Neurosci Lett 241:13-6